European Archives - Page 1360 of 1588 - European Medical Journal

Sailing Through September

With members of the EMJ team jetting off across Europe this month to attend a grand total of four medical congresses, which will of course be reviewed…

This September, EMJ Supports

With September having drawn to a close, the European Medical Journal (EMJ) looks back at the awareness campaigns we have supported this month: World…

Studying Protein Networks in Bowel Cancer

PROTEOMIC study of bowel cancer cells identifies common protein mutations and allows the prediction of treatment response….

Role of Gut Bacteria as a Parkinson’s Disease Biomarker

BACTERIAL communities in the gut of Parkinson’s patients differ to those of healthy people, potentially providing an early indicator of the…

Improving Patient-Doctor Communication: An Urgent Requirement for Better Patient Outcomes

Several healthcare professionals at the European Respiratory Society (ERS) International Congress 2017 expressed concerns with patient-doctor communication

Liver Disease: A Potential Protective Treatment Opportunity

PROTECTION against alcoholic liver disease may become possible thanks to new research surrounding the protein fibroblast growth factor 21 (FGF21). A…

New Therapeutic Target for Liver Cancer Revealed

PIONEERING research from the University of Maryland, Baltimore, Maryland, USA, has found a potential link between a relatively under-studied gene and…

Urinary Tract Infection Resistant Mutation Identified

A MUTATION altering the effect that levofloxacin, a quinolone antibiotic, has on pathogens causing urinary tract infections (UTI) has been identified by…

Immunotherapy to Advance Prostate Cancer Treatment

A NOVEL immunotherapy strategy for the treatment of prostate cancer using DNA-encoded monoclonal antibodies (DMAb) has shown promising results according…

β-Thalassaemias: Highlights from the European Hematology Association Scientific Working Group (EHA-SWG) Scientific Meeting on Anaemias: Diagnosis and Treatment in the Omics Era

β-thalassaemias are inherited blood disorders caused by a defect in the production of β-globin, giving rise to variable phenotypes.